多omics整合分析和关联研究揭示了ADIPOQ功能的潜力在妊娠糖尿病中
Xiaoying Li1, Tianshuang Jia1, Yingnan Wu1
1Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), No.158, Shangtang Road, Gongshu District, Hangzhou, Zhejiang, China.
Nutrition & diabetes
|March 2, 2025
概括
在ADIPOQ基因中的单核酸多态 (SNP) 与北中国妇女的妊娠糖尿病 (GDM) 有关. ADIPOQ在GDM转录调节和营养反应中发挥作用.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 生殖内分泌学 生殖内分泌学
- 分子生物学分子生物学
背景情况:
- 孕期糖尿病 (GDM) 对母亲和胎儿的健康构成风险.
- 编码adiponectin的ADIPOQ基因与代谢调节有关.
- 了解影响GDM的遗传因素对于早期发现和管理至关重要.
研究的目的:
- 调查ADIPOQ基因单核酸多态 (SNP) 与GDM风险之间的关联.
- 通过多奥米克分析,探索ADIPOQ在GDM病变发生中的作用.
主要方法:
- 在1157名北中国孕妇 (560名GDM,597名对照) 中,ADIPOQSNP (rs266729,rs1501299) 的基因定型.
- 多omics分析包括转录组,表观基因组和单细胞测序.
- 评估动脉的抽缩/腹缩 (S/D) 血流速度比.
主要成果:
- 在GDM患者中,特定的ADIPOQSNP基因型 (rs266729 CC,rs1501299 GG) 与动脉S/D比率较高有关.
- 在各种胎盘和免疫细胞 (EVT,T细胞,单细胞,NK细胞,SCT) 中检测到ADIPOQ的表达.
- 功能性丰富分析将ADIPOQ与营养反应和脂肪细胞分化联系起来.
结论:
- 在中国北方的人口中,ADIPOQ基因SNP与GDM相关.
- ADIPOQ参与了GDM的转录调节.
- 这些发现凸显了ADIPOQ作为GDM生物标志物和治疗点的潜力.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
842
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842
Glucagon-like Receptor Agonists
290
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
290
Oral Hypoglycemic Agents: Biguanides and Glitazones
151
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
151


